Market Overview

Wunderlich Suspends Hold Rating on BioMarin Pharmaceutical Inc., Removes $40.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BMRN

DateFirmActionFromTo
Mar 2017UBSInitiates Coverage OnNeutral
Mar 2017NomuraInitiates Coverage OnNeutral
Feb 2017Morgan StanleyInitiates Coverage OnOverweight

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: News Termination Analyst Ratings

 

Related Articles (BMRN)